Tme Pharma AG
Records under this name other than the patents Tme Pharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 6 of 6 · Back to Tme Pharma AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,513,536 | Methods for the preparation of a polyalkoxylated nucleic acid molecule Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,459,352 | Method for polyalkoxylation of nucleic acids that enables recovery and reuse of excess polyalkoxylation reagent Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,772,257 | SDF-1 Binding Nucleic Acids And The Use Thereof Lapsed on the fee record Ended Jul 8, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 8, 2026 | Medium confidence |
| US 9,988,636 | SDF-1 Binding Nucleic Acids and the Use Thereof Lapsed on the fee record Ended Jun 5, 2026 · Medium confidence | Lapsed on the fee record | Ended Jun 5, 2026 | Medium confidence |
| US 8,691,784 | MCP-1 binding nucleic acids Lapsed on the fee record Ended Apr 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | From the USPTO record |
| US 9,074,214 | Use of spiegelmers Lapsed on the fee record Ended Jul 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 7, 2023 | From the USPTO record |